메뉴 건너뛰기




Volumn 71, Issue 6, 2008, Pages 394-399

A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLACEBO; PREDNISONE; PYRIDOSTIGMINE; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; INOSINATE DEHYDROGENASE; MYCOPHENOLIC ACID;

EID: 49049115186     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000312373.67493.7f     Document Type: Article
Times cited : (212)

References (13)
  • 1
    • 3042602389 scopus 로고    scopus 로고
    • The epidemiology of myasthenia gravis
    • Phillips LH. The epidemiology of myasthenia gravis. Semin Neurol 2004;24:17-20.
    • (2004) Semin Neurol , vol.24 , pp. 17-20
    • Phillips, L.H.1
  • 2
    • 0021329141 scopus 로고
    • Long-term corticoste-roid treatment of myasthenia gravis: Report of 116 patients
    • Pascuzzi RM, Coslett B, Johns TR. Long-term corticoste-roid treatment of myasthenia gravis: report of 116 patients. Ann Neurol 1984;15:291-298.
    • (1984) Ann Neurol , vol.15 , pp. 291-298
    • Pascuzzi, R.M.1    Coslett, B.2    Johns, T.R.3
  • 3
    • 0035830461 scopus 로고    scopus 로고
    • Myco-phenolate mofetil for myasthenia gravis: An open-label pilot study
    • Ciafaloni E, Massey JM, Tucker-Lipscomb B, et al. Myco-phenolate mofetil for myasthenia gravis: An open-label pilot study. Neurology 2001;56:97-99.
    • (2001) Neurology , vol.56 , pp. 97-99
    • Ciafaloni, E.1    Massey, J.M.2    Tucker-Lipscomb, B.3
  • 4
    • 0035830428 scopus 로고    scopus 로고
    • Mycopheno-late mofetil: A safe and promising immunosuppressant in neu-romuscular diseases
    • Chaudhry V, Cornblath DR, Griffin JW, et al. Mycopheno-late mofetil: a safe and promising immunosuppressant in neu-romuscular diseases. Neurology 2001;56:94-96.
    • (2001) Neurology , vol.56 , pp. 94-96
    • Chaudhry, V.1    Cornblath, D.R.2    Griffin, J.W.3
  • 5
    • 4243397961 scopus 로고    scopus 로고
    • Mycophenolate mofetil is safe and well-tolerated in myasthenia gravis
    • Cos L, Mankodi AK, Tawil R, et al. Mycophenolate mofetil is safe and well-tolerated in myasthenia gravis. Neurology 2000;54(suppl 3):A137.
    • (2000) Neurology , vol.54 , Issue.SUPPL. 3
    • Cos, L.1    Mankodi, A.K.2    Tawil, R.3
  • 6
    • 0034641222 scopus 로고    scopus 로고
    • Myasthenia gravis: Recommendations for clinical research standards
    • Jaretzki A, Barohn RJ, Ernstoff RM, et al. Myasthenia gravis: recommendations for clinical research standards. Neurology 2000;55:16-23.
    • (2000) Neurology , vol.55 , pp. 16-23
    • Jaretzki, A.1    Barohn, R.J.2    Ernstoff, R.M.3
  • 7
    • 0031879064 scopus 로고    scopus 로고
    • Reliability testing of the quantitative myasthenia gravis score
    • Barohn RJ, McIntire D, Herbelin L, et al. Reliability testing of the quantitative myasthenia gravis score. Ann NY Acad Sci 1998;841:769-772.
    • (1998) Ann NY Acad Sci , vol.841 , pp. 769-772
    • Barohn, R.J.1    McIntire, D.2    Herbelin, L.3
  • 8
    • 0141838996 scopus 로고    scopus 로고
    • A simple manual muscle test for myasthenia gravis: Validation and comparison with the QMG score
    • Sanders DB, Tucker-Lipscomb B, Massey JM. A simple manual muscle test for myasthenia gravis: validation and comparison with the QMG score. Ann NY Acad Sci 2003; 998:440-444.
    • (2003) Ann NY Acad Sci , vol.998 , pp. 440-444
    • Sanders, D.B.1    Tucker-Lipscomb, B.2    Massey, J.M.3
  • 9
    • 0026877917 scopus 로고
    • The MOS 36-Item Short Form Health Survey (SF-36)
    • Ware JE, Sherbourne CD. The MOS 36-Item Short Form Health Survey (SF-36). Medical Care 1992;30: 473-481.
    • (1992) Medical Care , vol.30 , pp. 473-481
    • Ware, J.E.1    Sherbourne, C.D.2
  • 10
    • 0033594455 scopus 로고    scopus 로고
    • Myasthenia gravis activities of daily living profile
    • Wolfe GI, Herbelin L, Nations SP, et al. Myasthenia gravis activities of daily living profile. Neurology 1999;52:1487-1489.
    • (1999) Neurology , vol.52 , pp. 1487-1489
    • Wolfe, G.I.1    Herbelin, L.2    Nations, S.P.3
  • 11
    • 0027319951 scopus 로고
    • A clinical therapeutic trial of cyclosporine in myasthenia gravis
    • Tindall RSA, Phillips JT, Rollins JA, et al. A clinical therapeutic trial of cyclosporine in myasthenia gravis. Ann NY Acad Sci 1993;681:539-551.
    • (1993) Ann NY Acad Sci , vol.681 , pp. 539-551
    • Tindall, R.S.A.1    Phillips, J.T.2    Rollins, J.A.3
  • 12
    • 0019362251 scopus 로고
    • Introduction to sample size determination and power analysis for clinical trials
    • Lachin JM. Introduction to sample size determination and power analysis for clinical trials. Controlled Clin Trials 1981;2:93-113.
    • (1981) Controlled Clin Trials , vol.2 , pp. 93-113
    • Lachin, J.M.1
  • 13
    • 0344874547 scopus 로고    scopus 로고
    • Mycophe-nolate mofetil for myasthenia gravis: An analysis of efficacy, safety, and tolerability
    • Meriggioli MN, Ciafaloni E, Al Hayk KA, et al. Mycophe-nolate mofetil for myasthenia gravis: an analysis of efficacy, safety, and tolerability. Neurology 2003;61:1438-1440.
    • (2003) Neurology , vol.61 , pp. 1438-1440
    • Meriggioli, M.N.1    Ciafaloni, E.2    Al Hayk, K.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.